Progenics Pharmaceuticals (NASDAQ:PGNX)

Progenics Pharmaceuticals (NASDAQ:PGNX)


Share Price
$ 4.57
Change
0.28 (6.53 %)
Market Cap
$386.36 m
Proactive Investors - Run By Investors For Investors

Progenics Pharmaceuticals

Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company with programs in gastroenterology, oncology and virology focused on innovative therapeutics for patients with debilitating conditions and life-threatening diseases.
EPIC: PGNX
Market: NASDAQ:PGNX
52-week High/Low: $9.41 / $3.63
Sector: Pharmaceuticals
Market Cap: $386.36 m
Website: www.progenics.com
col 3
col 4
col 5
col 6

Progenics Pharmaceuticals Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use